Vaccine News and Research

Latest Vaccine News and Research

New therapeutic made from tobacco plants shown to arrest West Nile virus infection

A new therapeutic made from tobacco plants has been shown to arrest West Nile virus infection, according to a new study by Arizona State University scientist Qiang Chen and his colleagues.

2 Feb 2010

President's fiscal year 2011 budget: FDA requests $4.03 billion for promoting and protecting public health

The U.S. Food and Drug Administration is requesting $4.03 billion to promote and protect public health as part of the President's fiscal year 2011 budget - a 23 percent increase over the agency's current $3.28 billion budget.

2 Feb 2010

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

"We are delighted to be working with such esteemed institutions in order to generate cutting-edge therapeutic antibodies," said Matthew Baker, chief scientific officer and co-founder of Antitope. "This agreement combines our partners' expertise in novel therapeutic strategies with Antitope's expertise in engineering humanized antibodies to create therapeutic antibodies that may have a significant impact on the treatment of these major diseases."

2 Feb 2010

FDA and PATH collaborate to advance pneumococcal vaccine development for children

The U.S. Food and Drug Administration (FDA) today announced a collaboration with PATH to advance development of a vaccine to protect children against diseases caused by Streptococcus pneumoniae (pneumococcus), especially pneumonia.

2 Feb 2010

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

An experimental vaccine was found to reduce the rate of tuberculosis infections in patients living with HIV, "the first time a shot has been shown to reduce cases of the most common AIDS-related cause of death in poor nations," Bloomberg reports (Bennett, 1/29). Tuberculosis accounts for up to one-third of AIDS deaths worldwide, CBC News reports.

1 Feb 2010

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

Romark Laboratories announced that it has initiated enrollment of patients in a clinical trial of Alinia® (nitazoxanide) for treating acute uncomplicated influenza including illness caused by the currently circulating H1N1 strain.

1 Feb 2010

WHO pneumonia expert honored with PACE Global Leadership Award

WHO pneumonia expert Dr. Thomas Cherian will be honored by a group of the world’s leading infectious disease experts today for his pivotal work to accelerate access to vaccines preventing pneumococcal disease, the world’s leading vaccine-preventable killer of children under age five.

31 Jan 2010

PATH praises Gates Foundation for supporting vaccine development and delivery

Vaccination may be the most effective public health intervention of all time-especially in low-income countries, where many families can't access or afford health care when they are sick. On Friday, January 29, speaking at the World Economic Forum in Davos, Switzerland, Bill and Melinda Gates announced a new ten-year Gates Foundation commitment to funding vaccine development and delivery.

30 Jan 2010

New vaccine effective in preventing TB in HIV patients

Investigators from Dartmouth Medical School (DMS) have reported results of a clinical trial showing that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection.

30 Jan 2010

At World Economic Forum, Gates Foundation announces 10-year, $10B vaccine commitment

Bill and Melinda Gates announced Friday during the World Economic Forum in Davos, Switzerland, that their foundation would commit $10 billion over the next decade to research, develop and deliver vaccines for the world's poorest countries, the New York Times reports (McNeil, 1/29). The Gateses "said they hope the commitment would spur support by governments, corporations, and other donors for vaccinations efforts," the Chronicle of Philanthropy writes (Wilhelm, 1/29).

30 Jan 2010

Canada to donate 5m doses of H1N1 vaccine to WHO; agency has received commitment of 200m vaccines

The Canadian government on Thursday announced the country would donate five million doses of H1N1 vaccines to the WHO from the country's current surplus, the Canadian Press reports (Branswell, 1/28).

30 Jan 2010

Recent releases in Global Health

Rajiv Shah's appointment as USAID administrator "comes at a crucial time of challenge and opportunity for the Agency to improve the nutritional well-being of impoverished societies," write the authors of a Lancet Comment that examines the U.S. Global Hunger and Food Security Initiative. Though the initiative "sends a clear message to the world about U.S. intent to partner with poor nations to achieve their national food and nutrition goals … the Initiative's nutrition plan, unlike its detailed agricultural blueprint, currently lacks a comprehensive set of aims, activities, research needs, and programme benchmarks," the authors write.

29 Jan 2010

Bill & Melinda Gates Foundation commits $10 billion for vaccine research and development

Bill and Melinda Gates announced today that their foundation will commit $10 billion over the next 10 years to help research, develop and deliver vaccines for the world's poorest countries.

29 Jan 2010

Global market for oncology drugs is forecast to reach $80 billion by 2050

New Medicine's Oncology KnowledgeBASE (nm/OK) residing at http://nmok.net became available on the Internet 10 years ago and, since then, the oncology field has evolved into one of the most challenging, complex and promising drug development sectors, both in terms of its potential contribution to medicine and to its market opportunities.

29 Jan 2010

Econiche vaccine cited in February, 2010 issue of Scientific American

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that Econiche(TM), the world's first vaccine developed to reduce the shedding by cattle of Escherichia coli (E. coli) O157, has been cited in the February, 2010 issue of Scientific American (Vol. 302, # 2).

29 Jan 2010

Diabetes vaccine: Diamyd Medical to file for market approval in 2011

In her comments in today’s quarterly report Elisabeth Lindner, President and CEO of Diamyd Medical, says that the Company’s objective is to file the Diamyd® diabetes vaccine for market approval in 2011 - a goal that isn’t very far off now.

29 Jan 2010

Experimental vaccine protects mice and monkeys against chikungunya virus

An experimental vaccine developed using non-infectious virus-like particles (VLP) has protected macaques and mice against chikungunya virus, a mosquito-borne pathogen that has infected millions of people in Africa and Asia and causes debilitating pain, researchers at the National Institutes of Health have found.

29 Jan 2010

Findings could guide in developing more effective vaccines for HIV/AIDS and cancer

In an acute viral infection, most of the white blood cells known as T cells differentiate into cells that fight the virus and die off in the process. But a few of these "effector" T cells survive and become memory T cells, ensuring that the immune system can respond faster and stronger the next time around.

29 Jan 2010

Mandatory influenza vaccination policy improves immunization rates among health care workers

A mandatory influenza vaccination policy improves immunization rates among health care workers, according to a recent study of a large health care organization.

29 Jan 2010

Watson Pharmaceuticals acquires Eden Biopharm Group for approximately $15M

Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of Eden Biopharm Group Limited for approximately $15 million. Eden is a biopharmaceutical development and contract manufacturing company located in Liverpool, UK. As a result of the acquisition of the Arrow Group in December 2009, Watson had previously acquired approximately 36 percent of Eden.

29 Jan 2010

Vaccine News and Research

Latest Vaccine News and Research

New therapeutic made from tobacco plants shown to arrest West Nile virus infection

President's fiscal year 2011 budget: FDA requests $4.03 billion for promoting and protecting public health

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

FDA and PATH collaborate to advance pneumococcal vaccine development for children

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

WHO pneumonia expert honored with PACE Global Leadership Award

PATH praises Gates Foundation for supporting vaccine development and delivery

New vaccine effective in preventing TB in HIV patients

At World Economic Forum, Gates Foundation announces 10-year, $10B vaccine commitment

Canada to donate 5m doses of H1N1 vaccine to WHO; agency has received commitment of 200m vaccines

Recent releases in Global Health

Bill & Melinda Gates Foundation commits $10 billion for vaccine research and development

Global market for oncology drugs is forecast to reach $80 billion by 2050

Econiche vaccine cited in February, 2010 issue of Scientific American

Diabetes vaccine: Diamyd Medical to file for market approval in 2011

Experimental vaccine protects mice and monkeys against chikungunya virus

Findings could guide in developing more effective vaccines for HIV/AIDS and cancer

Mandatory influenza vaccination policy improves immunization rates among health care workers

Watson Pharmaceuticals acquires Eden Biopharm Group for approximately $15M

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in